Fujian Wanchen Biotechnology Group Co., Ltd. (SHE: 300972)
China
· Delayed Price · Currency is CNY 79.39
-1.02 (-1.27%)
Jan 2, 2025, 4:00 PM CST
Fujian Wanchen Biotechnology Group Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | 57.69 | -82.93 | 47.74 | 23.45 | 96.13 | 92.19 | Upgrade
|
| Depreciation & Amortization | 182 | 182 | 64.48 | 61.32 | 59.61 | 59.72 | Upgrade
|
| Other Amortization | 10.1 | 10.1 | 1 | - | - | 0.46 | Upgrade
|
| Loss (Gain) From Sale of Assets | 3.26 | 3.26 | 1.66 | 0.49 | 0.1 | 0.15 | Upgrade
|
| Asset Writedown & Restructuring Costs | 4.04 | 4.04 | 0.31 | 0.1 | 0.05 | 0.62 | Upgrade
|
| Loss (Gain) From Sale of Investments | -0.06 | -0.06 | -1.72 | -1.8 | - | - | Upgrade
|
| Provision & Write-off of Bad Debts | 0.7 | 0.7 | 0.78 | 0.05 | 0.01 | 0.29 | Upgrade
|
| Other Operating Activities | 870.04 | -22.75 | -1.99 | 5.18 | 8.48 | 14.68 | Upgrade
|
| Change in Accounts Receivable | -338.41 | -338.41 | -53.22 | -7.39 | 0.33 | 7.5 | Upgrade
|
| Change in Inventory | -635.44 | -635.44 | -44.73 | -4.57 | -9.16 | 1.39 | Upgrade
|
| Change in Accounts Payable | 1,754 | 1,754 | 54.56 | 22 | 0.7 | 0.28 | Upgrade
|
| Change in Other Net Operating Assets | 147.97 | 147.97 | 1.48 | - | - | - | Upgrade
|
| Operating Cash Flow | 2,056 | 1,023 | 70.38 | 98.82 | 156.24 | 177.28 | Upgrade
|
| Operating Cash Flow Growth | - | 1353.60% | -28.78% | -36.75% | -11.87% | 73.71% | Upgrade
|
| Capital Expenditures | -187.97 | -218.91 | -316.34 | -41.57 | -56.1 | -39.73 | Upgrade
|
| Sale of Property, Plant & Equipment | 32.3 | 17.55 | 0.36 | 0.37 | 0.2 | 0.15 | Upgrade
|
| Cash Acquisitions | -5.4 | -5.4 | - | - | - | - | Upgrade
|
| Investment in Securities | -293.94 | 0.06 | 20 | -18.23 | - | - | Upgrade
|
| Other Investing Activities | -0.06 | - | 1.76 | - | - | - | Upgrade
|
| Investing Cash Flow | -455.07 | -206.69 | -294.22 | -59.43 | -55.9 | -39.58 | Upgrade
|
| Long-Term Debt Issued | - | 598.22 | 265.97 | 90.7 | 88 | 105.98 | Upgrade
|
| Long-Term Debt Repaid | - | -381.64 | -114.49 | -175.35 | -129.86 | -187.64 | Upgrade
|
| Net Debt Issued (Repaid) | 287.93 | 216.58 | 151.47 | -84.65 | -41.86 | -81.66 | Upgrade
|
| Issuance of Common Stock | 305.08 | 9.45 | - | 245.42 | - | - | Upgrade
|
| Common Dividends Paid | -30.21 | -15.15 | -39.22 | -5.23 | -49.01 | -94.69 | Upgrade
|
| Dividends Paid | -30.21 | -15.15 | -39.22 | -5.23 | -49.01 | -94.69 | Upgrade
|
| Other Financing Activities | -186.78 | 11.39 | 10.41 | -12.26 | -3.08 | -0.96 | Upgrade
|
| Financing Cash Flow | 376.02 | 222.26 | 122.66 | 143.28 | -93.95 | -177.31 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0 | -0 | - | - | -0 | - | Upgrade
|
| Net Cash Flow | 1,977 | 1,039 | -101.17 | 182.67 | 6.39 | -39.61 | Upgrade
|
| Free Cash Flow | 1,869 | 804.17 | -245.96 | 57.25 | 100.14 | 137.55 | Upgrade
|
| Free Cash Flow Growth | - | - | - | -42.83% | -27.20% | - | Upgrade
|
| Free Cash Flow Margin | 7.47% | 8.65% | -44.78% | 13.17% | 22.25% | 30.50% | Upgrade
|
| Free Cash Flow Per Share | 10.72 | 5.23 | -1.59 | 0.41 | 0.88 | 1.19 | Upgrade
|
| Cash Income Tax Paid | 449.21 | 93.11 | 9.01 | 3.49 | 2.98 | 2.87 | Upgrade
|
| Levered Free Cash Flow | 1,503 | 912.09 | -256.14 | 40.51 | 34.82 | 65.39 | Upgrade
|
| Unlevered Free Cash Flow | 1,536 | 930.05 | -253.51 | 43.74 | 39.54 | 74.13 | Upgrade
|
| Change in Net Working Capital | -978.63 | -837.84 | 22.73 | -16.07 | 26.1 | 11.69 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.